bn:02004131n
Noun Concept
EL
No term available
EN
Esreboxetine is a selective norepinephrine reuptake inhibitor which was under development by Pfizer for the treatment of neuropathic pain and fibromyalgia but failed to show significant benefit over currently available medications and was discontinued. Wikipedia
Relations
Sources